MEDLINE

Lobbying for MEDLINE · Medical product manufacturing and distribution

Filing 4th Quarter - Report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 19, 2026

Expenses

$490,000.00

What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

Illinois

Official filing document

Government bodies contacted 10

Bureau of Industry and Security (BIS)
Commerce, Dept of (DOC)
Food & Drug Administration (FDA)
Health & Human Services, Dept of (HHS)
HOUSE OF REPRESENTATIVES
Intl Trade Administration (ITA)
SENATE
Treasury, Dept of
U.S. Customs & Border Protection
U.S. Trade Representative (USTR)

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 2

Health Issues

Healthcare supply chain and resiliency, issues related to medical provider reimbursement and federal funding for Medicaid and Medicare.

Trade (domestic/foreign)

Issues related to tariffs and healthcare supply chain, reauthorization of the African Growth and Opportunity Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.